Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway

Fig. 1

High expression level of BCL-2 predicts sensitivity to BM1197. a. Basal protein expression of Bcl-2 family protein in lymphoma cell lines. b. BM-1197 inhibits the proliferation of nine lymphoma cell lines in a dose-dependent manner. c. The inhibition of BM-1197 on OCI-ly8 cells is in a time-dependent way. d. The combination curve of BM-1197 with ADM inOCI-ly8 cells. e. The combination curve of BM-1197 with GEM inOCI-ly8 cells. f. The combination curve of BM-1197 with VCR inOCI-ly8 cells

Back to article page